Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $69.92 million. The enterprise value is $2.36 million.

Market Cap	69.92M
Enterprise Value	2.36M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.50 million shares outstanding. The number of shares has increased by 0.44% in one year.

Shares Outstanding	6.50M
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	65.92%
Float	3.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.23, with a Debt / Equity ratio of 0.37.

Current Ratio	15.23
Quick Ratio	n/a
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.96

Financial Efficiency

Return on equity (ROE) is -58.50% and return on invested capital (ROIC) is -51.32%.

Return on Equity (ROE)	-58.50%
Return on Assets (ROA)	-41.60%
Return on Capital (ROIC)	-51.32%
Revenue Per Employee	n/a
Profits Per Employee	-$3.19M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.32% in the last 52 weeks. The beta is 1.25, so Instil Bio's price volatility has been higher than the market average.

Beta (1Y)	1.25
52-Week Price Change	-16.32%
50-Day Moving Average	11.45
200-Day Moving Average	9.49
Relative Strength Index (RSI)	45.67
Average Volume (30 Days)	18,367

Short Selling Information

The latest short interest is 8,747, so 0.13% of the outstanding shares have been sold short.

Short Interest	8,747
Short Previous Month	15,019
Short % of Shares Out	0.13%
Short % of Float	0.29%
Short Ratio (days to cover)	0.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-159.17M
Pretax Income	-156.09M
Net Income	-156.09M
EBITDA	-145.48M
EBIT	-150.88M
Earnings Per Share (EPS)	-$24.00

Full Income Statement

Balance Sheet

The company has $151.86 million in cash and $84.30 million in debt, giving a net cash position of $67.55 million or $10.39 per share.

Cash & Cash Equivalents	151.86M
Total Debt	84.30M
Net Cash	67.55M
Net Cash Per Share	$10.39
Equity / Book Value	225.83M
Book Value Per Share	34.72
Working Capital	150.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$82.03 million and capital expenditures -$20.66 million, giving a free cash flow of -$102.69 million.

Operating Cash Flow	-82.03M
Capital Expenditures	-20.66M
Free Cash Flow	-102.69M
FCF Per Share	-$15.79

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.44%
Shareholder Yield	-0.44%
Earnings Yield	-223.25%
FCF Yield	-146.88%

Analyst Forecast

The average price target for Instil Bio is $27.67, which is 157.40% higher than the current price. The consensus rating is "Buy".

Price Target	$27.67
Price Target Difference	157.40%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2